Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bogen

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|March 1, 1992
Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densitiesB Bogen, L Gleditsch, S Weiss, et al.
Clinical and Experimental Immunology|November 1, 1982
Monoclonal hybridoma antibodies to human amyloid related protein SAAG Marhaug, G Gaudernack, B Bogen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumorsG F Lauritzsen, S Weiss, Z Dembic, et al.
Scandinavian Journal of Immunology|July 12, 2013
A public T cell receptor recognized by a monoclonal antibody specific for the D-J junction of the β-chainT Frigstad, G Å Løset, I Sandlie, et al.
Scandinavian Journal of Immunology|September 30, 2011
Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccineI Øynebråten, T-O Løvås, K Thompson, et al.
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Deletion of idiotype (Id)-specific T cells in multiple myelomaB Bogen, K Schenck, L A Munthe, et al.
Scandinavian Journal of Immunology|July 9, 2004
Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic miceZ Dembic, P O Hofgaard, H Omholt, et al.
Scandinavian Journal of Immunology|December 1, 1995
Preferential positive selection of T lymphocytes which express two different TCR alpha chains, an endogenous and a transgenicL A Munthe, A Sollien, Z Dembic, et al.
European Journal of Immunology|November 1, 1986
Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable regionB Bogen, R Snodgrass, J P Briand, et al.
International Journal of Cancer|October 1, 1998
Clonal deletion of thymocytes as a tumor escape mechanismG F Lauritzsen, P O Hofgaard, K Schenck, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|March 1, 1992
Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densitiesB Bogen, L Gleditsch, S Weiss, et al.
Clinical and Experimental Immunology|November 1, 1982
Monoclonal hybridoma antibodies to human amyloid related protein SAAG Marhaug, G Gaudernack, B Bogen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumorsG F Lauritzsen, S Weiss, Z Dembic, et al.
Scandinavian Journal of Immunology|July 12, 2013
A public T cell receptor recognized by a monoclonal antibody specific for the D-J junction of the β-chainT Frigstad, G Å Løset, I Sandlie, et al.
Scandinavian Journal of Immunology|September 30, 2011
Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccineI Øynebråten, T-O Løvås, K Thompson, et al.
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Deletion of idiotype (Id)-specific T cells in multiple myelomaB Bogen, K Schenck, L A Munthe, et al.
Scandinavian Journal of Immunology|July 9, 2004
Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic miceZ Dembic, P O Hofgaard, H Omholt, et al.
Scandinavian Journal of Immunology|December 1, 1995
Preferential positive selection of T lymphocytes which express two different TCR alpha chains, an endogenous and a transgenicL A Munthe, A Sollien, Z Dembic, et al.
European Journal of Immunology|November 1, 1986
Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable regionB Bogen, R Snodgrass, J P Briand, et al.
International Journal of Cancer|October 1, 1998
Clonal deletion of thymocytes as a tumor escape mechanismG F Lauritzsen, P O Hofgaard, K Schenck, et al.
Pageof 9